Search the Newsreel

Quantinno Capital Management LP Acquires 23,834 Shares of TechnipFMC plc $FTI

Quantinno Capital Management LP increased its stake in TechnipFMC plc by 40% in the first quarter, now holding 83,415 shares valued at $5.77 million. This move comes as TechnipFMC reported strong quarterly earnings, beating analyst estimates, and revenue grew 9% year-over-year. The company also …

TechnipFMC PLC (FTI) Aktuelle Aktien-News

AppFolio director Maurice Duca sells $2.54 million in company stock

AppFolio director Maurice Duca sold approximately $2.54 million worth of Class A Common Stock between August 4 and August 5, 2026, through a pre-arranged 10b5-1 trading plan. The sales involved 12,766 shares, both directly and indirectly through trusts. This comes as AppFolio reported a …

Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other Players

Company Logo Dublin, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market: 2026 Edition" has been added to ResearchAndMarkets.com's offering. The global influenza vaccine market was valued at US$8.96 billion in 2024 and is projected to reach US$13.32 billion by 2030, expanding …

Projeções de Resultados: TechnipFMC PLC (FTI) — LPA e Crescimento de Receita

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

Pfizer, Merck, and Amgen are expanding their cancer portfolios, leading to increased speculation about smaller oncology companies like Sellas Life Sciences (SLS) and ImmunityBio (IBRX) being potential acquisition targets. Pfizer's Seagen portfolio and Padcev, Merck's sac-TMT, and Amgen's T-cell engagers and Imdelltra are key …

FTI|TechnipFMC PLC|Price:69.620|Chg%:-0.030

Earnings To Watch: OppFi Inc (OPFI) Q2 2026 -- GF Value Sees 74% Downside

Warum die Pfizer-Aktie (PFE) trotz eines Nettoverlusts im zweiten Quartal um 5,2 % gestiegen ist, nachdem das Unternehmen seine Prognose für 2026 angehoben hat

Why Pfizer (PFE) Is Up 5.2% After Raising 2026 Guidance Despite a Q2 Net Loss

Hovnanian Enterprises schedules fiscal Q3 earnings release and conference call

Hovnanian Enterprises (NYSE: HOV) announced its fiscal Q3 2026 earnings release and conference call. The company will release results for the period ended July 31, 2026, on August 20, 2026, with the conference call scheduled for 11:00 a.m. ET on the same day via …

Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Novavax Inc (NASDAQ:NVAX) has secured licensing or material transfer agreements with 4 of the TOP10 …

Pfizer Inc Earnings Call Signals Cautious Optimism

Pfizer Inc.'s Q2 earnings call revealed cautious optimism, with core revenues and adjusted EPS surpassing expectations, leading to raised full-year revenue guidance. The company demonstrated strong performance in oncology and neuroscience, alongside significant R&D activity, despite setbacks from a clinical trial miss, weaker COVID …

Pfizer shares rise after strong Q2 earnings des...

GMM Pfaudler Q1 Results: Earnings call audio released for Q1FY27

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE) and Allogene Therapeutics (ALLO)

This article provides analyst ratings and price targets for three healthcare companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE), and Allogene Therapeutics (ALLO). Citi analyst Geoff Meacham maintained a Hold rating on Pfizer, while Citi analyst Yigal Nochomovitz maintained a Buy rating on Ultragenyx Pharmaceutical. William …

Earnings call transcript: GMM Pfaudler Q1 2026 stock jumps 17% on backlog

OppFi Inc. Share Price Live Today – NYSE:OPFI Stock Price, Chart, News, History

Pfizer (PFE) Stock Trades At A Premium Despite Its 27% Five Year Fall

Pfizer’s Q2 Earnings Beat by Double Digits. A $4.3 Billion Writedown Stole the Headline.

Pfizer (PFE) Could Be 12% Undervalued Following Raised 2026 Revenue Guidance

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Pfizer (PFE) is back in focus after its second quarter 2026 update, which paired a reported net loss and sizeable non cash impairments with higher full year …

TechnipFMC PLC stock underperforms Wednesday when compared to competitors

TechnipFMC PLC (FTI) stock fell 1.07% on Wednesday, closing at $69.27, while the broader market saw mixed results with the Dow Jones Industrial Average rising and the S&P 500 Index falling. The company's shares are currently trading 11.10% below their 52-week high of $77.92. …

Principal Global Investors (APPF) reports 6.4% stake in AppFolio Class A shares

Principal Global Investors has reported a beneficial ownership of 1,549,609 shares of AppFolio Inc.'s Class A common stock, representing 6.4% of the class. This disclosure, made via an amended Schedule 13G filing, indicates shared voting and dispositive power over all these shares. The filing …

Pfizer Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:PFE) 2026-08-04

This article provides access to the slide deck published by Pfizer Inc. in conjunction with their Q2 2026 earnings call. The report highlights that Pfizer's EPS of $0.77 beat expectations by $0.09, and revenue of $15.03 billion, up 2.60% year-over-year, beat by $645.82 million.

Pfizer Stock Slips Despite Earnings Beat and $2.5 Billion Cuts

This article first appeared on GuruFocus. Pfizer (NYSE:PFE), the pharmaceutical giant behind some of the world's biggest blockbuster drugs, edged about 0.5% lower in Tuesday's early trading despite delivering another earnings beat and raising its revenue outlook. The market appeared unconvinced that better quarterly …

Pfizer Q2 Earnings Call Highlights Non-COVID Growth and Cost Cuts

Pfizer Inc. PFE used its second-quarter 2026 earnings call to stress that stronger non-COVID products are offsetting a weak infection season as investment targets oncology and obesity. Management raised the midpoint of full-year revenue guidance, expanded savings targets and reinforced the dividend. The call …

ETFs Investing in AppFolio Inc Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold AppFolio Inc. Class A (APPF) stocks. It provides a detailed table with each ETF's market value, weight of APPF stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative …

Company News for Aug 5, 2026

Allison Transmission Holdings Inc.'s (ALSN) shares surged 5.4% after reporting second-quarter 2026 adjusted earnings of $2.73 per share, surpassing the Zacks Consensus Estimate of $2.60 per share. Shares of The Clorox Co. (CLX) climbed 6.5% after posting fourth-quarter fiscal 2026 adjusted earnings of $1.66 …

TechnipFMC plc $FTI Position Cut by Centaurus Financial Inc.

Centaurus Financial Inc. significantly reduced its stake in TechnipFMC plc (NYSE:FTI) by 95.7% in the first quarter, selling 35,958 shares and leaving it with 1,620 shares valued at $112,000. Meanwhile, other institutional investors like State Street Corp, Norges Bank, and Invesco Ltd. substantially increased …

Is AppFolio (APPF) A Bargain As Earnings And Guidance Lift Its Valuation Debate?

AppFolio (APPF) is under valuation scrutiny after strong Q2 2026 earnings and raised full-year guidance led to a stock rebound, though it remains down over the past year. While one analysis suggests it's 16.4% undervalued with a fair value of $229.25, its high P/E …

Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.

Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand. Continue Reading

Pfizer (PFE) Stock Faces Pipeline Doubts After Higher Revenue Outlook

TechnipFMC (NYSE: FTI) EVP has 1,494 shares withheld to cover taxes

TechnipFMC EVP, Chief Legal Officer & Secretary, Cristina Aalders, had 1,494 Ordinary Shares withheld to cover taxes related to the vesting of restricted stock units. This transaction, valued at $69.19 per share, was not an open-market sale but a tax-withholding disposition on August 3, …

TechnipFMC PLC stock rises Tuesday, still underperforms market

TechnipFMC PLC (FTI) saw its stock rise by 1.20% to $70.02 on Tuesday, despite the broader market, including the S&P 500 Index and Dow Jones Industrial Average, also experiencing gains. However, the company's stock still closed 10.14% below its 52-week high of $77.92, achieved …

Pfizer Earnings Reveal New Engine Beyond Covid

This article first appeared on GuruFocus. Pfizer (NYSE:PFE) delivered stronger-than-expected second-quarter results as Specialty Care and newer acquired medicines offset continued weakness across Primary Care, reinforcing the company's transition away from pandemic-era products. The split matters because Pfizer's recovery increasingly depends on specialty drugs …

Pfizer beats earnings estimates, targets US$2.5 billion in additional cost cuts

Pfizer reported strong Q2 results, exceeding earnings estimates, driven by demand for Eliquis and acquired drugs. The company announced plans for an additional $2.5 billion in cost cuts, aiming for a total of $9.7 billion in net savings by 2029 to offset declining COVID-related …